Literature DB >> 14530866

Increased sucrose permeability in Behçet's disease.

Bayram Koc1, Serdar Aymelek, Alper Sonmez, M Ilker Yilmaz, Hakki Kocar.   

Abstract

Behçet's disease (BD) is a chronic, relapsing, systemic vasculitis with unknown etiology. During the progression of the disease, gastrointestinal involvement can be observed. The aim of this study was to find out the predictive value of the sucrose permeability test in detecting gastrointestinal mucosal damage in BD. Twenty-six male Behçet's patients and 21 age- and sex-matched controls were enrolled in the study. Seventeen patients had active disease, while nine did not. Active disease was defined as having elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels or at least two of the diagnostic criteria in the previous month. Patients and controls were investigated with the upper gastrointestinal permeability test. Of all the patients, 25 were investigated endoscopically. The urine sucrose levels were significantly higher in patients than in the control group (P = 0.0001) and in patients with active disease than those with inactive disease (P < 0.0001), while urine sucrose of patients with inactive disease and the control group did not differ. The endoscopic findings were not specific to BD. Active and inactive BD had similar endoscopic findings. Increased upper gastrointestinal permeability was established in patients with BD. This increased permeability was not related to a specific gastrointestinal BD lesion. Further studies with larger series must be performed in order to determine the value of the sucrose permeability test in detecting mucosal involvement in BD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14530866     DOI: 10.1007/s00296-003-0375-3

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  27 in total

Review 1.  Intestinal permeability tests in coeliac disease.

Authors:  S D Johnston; M Smye; R P Watson
Journal:  Clin Lab       Date:  2001       Impact factor: 1.138

Review 2.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

Review 3.  Bowel inflammation and the spondyloarthropathies.

Authors:  F De Keyser; D Elewaut; M De Vos; K De Vlam; C Cuvelier; H Mielants; E M Veys
Journal:  Rheum Dis Clin North Am       Date:  1998-11       Impact factor: 2.670

4.  Gastrointestinal involvement in Behçet's syndrome: a controlled study.

Authors:  S Yurdakul; N Tüzüner; I Yurdakul; V Hamuryudan; H Yazici
Journal:  Ann Rheum Dis       Date:  1996-03       Impact factor: 19.103

Review 5.  Intestinal permeability: an overview.

Authors:  I Bjarnason; A MacPherson; D Hollander
Journal:  Gastroenterology       Date:  1995-05       Impact factor: 22.682

6.  Polarized Caco-2 cells. Effect of reactive oxygen metabolites on enterocyte barrier function.

Authors:  R D Baker; S S Baker; K LaRosa
Journal:  Dig Dis Sci       Date:  1995-03       Impact factor: 3.199

7.  Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs.

Authors:  E Smecuol; J C Bai; E Sugai; H Vazquez; S Niveloni; S Pedreira; E Mauriño; J Meddings
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

8.  A simple, non-invasive marker of gastric damage: sucrose permeability.

Authors:  L R Sutherland; M Verhoef; J L Wallace; G Van Rosendaal; R Crutcher; J B Meddings
Journal:  Lancet       Date:  1994-04-23       Impact factor: 79.321

9.  Sucrose: a novel permeability marker for gastroduodenal disease.

Authors:  J B Meddings; L R Sutherland; N I Byles; J L Wallace
Journal:  Gastroenterology       Date:  1993-06       Impact factor: 22.682

10.  Nitric oxide synthase activity, viability and cyclic GMP levels in rat colonic epithelial cells: effect of endotoxin challenge.

Authors:  B L Tepperman; J F Brown; R Korolkiewicz; B J Whittle
Journal:  J Pharmacol Exp Ther       Date:  1994-12       Impact factor: 4.030

View more
  1 in total

1.  Neutrophil-mediated mechanisms of damage and in-vitro protective effect of colchicine in non-vascular Behçet's syndrome.

Authors:  Alessandra Bettiol; Matteo Becatti; Elena Silvestri; Flavia Rita Argento; Eleonora Fini; Amanda Mannucci; Silvia Galora; Irene Mattioli; Maria Letizia Urban; Danilo Malandrino; Adalgisa Palermo; Niccolò Taddei; Giacomo Emmi; Domenico Prisco; Claudia Fiorillo
Journal:  Clin Exp Immunol       Date:  2021-10-08       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.